Abstract
The wide clinical spectrum of the ABCB4 gene (ATP-binding cassette subfamily B member 4) deficiency syndromes in humans includes low phospholipid-associated cholelithiasis (LPAC), intrahepatic cholestasis of pregnancy (ICP), oral contraceptives-induced cholestasis (CIC), and progressive familial intrahepatic cholestasis type 3 (PFIC3). No ABCB4 mutations are found in a significant proportion of patients with these syndromes. In the present study, 102 unrelated adult patients with LPAC (43 patients) or CIC/ICP (59 patients) were screened for ABCB4 mutations using DNA sequencing. Heterozygous ABCB4 point or short insertion/deletion mutations were found in 37% (16/43) of the LPAC patients and in 27% (16/59) of the ICP/CIC patients. High-resolution gene dosage methodologies were used in the 70 negative patients. Here, we describe for the first time ABCB4 partial or complete heterozygous deletions in 7% (3/43) of the LPAC patients, and in 2% (1/59) of the ICP/CIC patients. Our observations urge to systematically test patients with LPAC, ICP/CIC, and also children with PFIC3 for the presence of ABCB4 deletions using molecular tools allowing detection of gross rearrangements. In clinical practice, a comprehensive ABCB4 alteration-screening algorithm will permit the use of ABCB4 genotyping to confirm the diagnosis of LPAC or ICP/CIC, and allow familial testing. An early diagnosis of these biliary diseases may be beneficial because of the preventive effect of ursodeoxycholic acid on biliary complications. Further comparative studies of patients with well-characterized genotypes (including deletions) and phenotypes will help determine whether ABCB4 mutation types influence clinical outcomes.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Accession codes
References
Oude Elferink RP, Paulusma CC, Groen AK : Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology 2006; 130: 908–925.
Lincke CR, Smit JJ, van der Velde-Koerts T, Borst P : Structure of the human MDR3 gene and physical mapping of the human MDR locus. J Biol Chem 1991; 266: 5303–5310.
Oude Elferink RP, Paulusma CC : Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Eur J Physiol 2007; 453: 601–610.
Lucena JF, Herrero JI, Quiroga J et al: A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003; 124: 1037–1042.
Kano M, Shoda J, Sumazaki R, Oda K, Nimura Y, Tanaka N : Mutations identified in the human multidrug resistance P-glycoprotein 3 (ABCB4) gene in patients with primary hepatolithiasis. Hepatol Res 2004; 29: 160–166.
Jung C, Driancourt C, Baussan C et al: Prenatal molecular diagnosis of inherited cholestatic diseases. J Pediatr Gastroenterol Nutr 2007; 44: 453–458.
Jacquemin E, de Vree JM, Cresteil D et al: The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120: 1448–1458.
Rosmorduc O, Hermelin B, Boelle PY, Poupon RE, Poupon R, Chazouillères O : ABCB4 gene mutations and primary sclerosing cholangitis. Gastroenterology 2004; 126: 1220–1222.
Ziol M, Barbu V, Rosmorduc O et al: ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults. Gastroenterology 2008; 135: 131–141.
Denk GU, Bikker H, Lekanne Dit Deprez RH et al: ABCB4 deficiency: a family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene. Hepatol Res 2010; 40: 937–941.
Poupon R, Arrive L, Rosmorduc O : The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults. Gastroenterol Clin Biol 2010; 34: 380–387.
De Vree JM, Jacquemin E, Sturm E et al: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998; 95: 282–287.
Colombo C, Vajro P, Degiorgio D et al: Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr 2011; 52: 73–83.
Degiorgio D, Colombo C, Seia M et al: Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3). Eur J Hum Genet 2007; 15: 1230–1238.
Deleuze JF, Jacquemin E, Dubuisson C et al: Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904–908.
Maggiore G, Bernard O, Hadchouel M, Lemonnier A, Alagille D : Diagnostic value of serum gamma-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr 1991; 12: 21–26.
Rosmorduc O, Hermelin B, Poupon R : MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001; 120: 1459–1467.
Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R : ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003; 125: 452–459.
Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E : The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 2010; 30: 134–146.
Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M : Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210–211.
Dixon PH, Weerasekera N, Linton KJ et al: Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9: 1209–1217.
Gendrot C, Bacq Y, Brechot MC, Lansac J, Andres C : A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40: e32.
Müllenbach R, Linton KJ, Wiltshire S et al: ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40: e70.
Pauli-Magnus C, Kerb R, Fattinger K et al: BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 2004; 39: 779–791.
Keitel V, Vogt C, Häussinger D, Kubitz R : Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 2006; 131: 624–629.
Wasmuth HE, Glantz A, Keppeler H et al: Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut 2007; 56: 265–270.
Hay JE : Liver disease in pregnancy. Hepatology 2008; 47: 1067–1076.
Schneider G, Paus TC, Kullak-Ublick GA et al: Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 2007; 45: 150–158.
Floreani A, Carderi I, Paternoster D et al: Intrahepatic cholestasis of pregnancy; three novel MDR3 gene mutations. Aliment Pharmacol Ther 2006; 23: 1649–1653.
Floreani A, Carderi I, Paternoster D et al: Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis 2008; 40: 366–370.
Bacq Y, Gendrot C, Perrotin F et al: ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J Med Genet 2009; 46: 711–715.
Mazzella G, Rizzo N, Azzaroli F et al: Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001; 33: 504–508.
Paus TC, Schneider G, Van De Vondel P V, Sauerbruch T, Reichel C : Diagnosis and therapy of intrahepatic cholestasis of pregnancy. Z Gastroenterol 2004; 42: 623–628.
Pauli-Magnus C, Meier PJ : Hepatobiliary transporters and drug-induced cholestasis. Hepatology 2006; 44: 778–787.
Ganne-Carrié N, Baussan C, Grando V, Gaudelus J, Cresteil D, Jacquemin E : Progressive familial intrahepatic cholestasis type 3 revealed by oral contraceptive pills. J Hepatol 2003; 38: 693–694.
Lang C, Meier Y, Stieger B et al: Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 2007; 17: 47–60.
Poupon R, Barbu V, Chamouard P, Wendum D, Rosmorduc O, Housset C : Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3. Liver Int 2010; 30: 327–331.
Pasmant E, de Saint-Trivier A, Laurendeau I, Dieux-Coeslier A, Parfait B, Vidaud M et al: Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient. Eur J Hum Genet 2008; 16: 1459–1466.
Pasmant E, Sabbagh A, Masliah-Planchon J et al: Detection and characterization of NF1 microdeletions by custom high resolution array CGH. J Mol Diagn 2009; 11: 524–529.
Chen JM, Cooper DN, Férec C, Kehrer-Sawatzki H, Patrinos GP : Genomic rearrangements in inherited disease and cancer. Semin Cancer Biol 2010; 20: 222–233.
Hardikar W, Kansal S, Oude Elferink RP, Angus P : Intrahepatic cholestasis of pregnancy: when should you look further? World J Gastroenterol 2009; 15: 1126–1129.
Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN : Complex gene rearrangements caused by serial replication slippage. Hum Mutat 2005; 26: 125–134.
Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN : Intrachromosomal serial replication slippage in trans gives rise to diverse genomic rearrangements involving inversions. Hum Mutat 2005; 26: 362–373.
Acknowledgements
We thank the patients for their participation. We thank all the clinicians from France, who provided the samples for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website
Rights and permissions
About this article
Cite this article
Pasmant, E., Goussard, P., Baranes, L. et al. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis. Eur J Hum Genet 20, 277–282 (2012). https://doi.org/10.1038/ejhg.2011.186
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2011.186
Keywords
This article is cited by
-
A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report
BMC Medical Genomics (2023)
-
Clinical utility gene card for: Progressive familial intrahepatic cholestasis type 3
European Journal of Human Genetics (2014)
